Abstract
Background and Aim: Sepsis is a major cause of disease and death in newborns. This study largely aims to assess the outcomes of newborns with sepsis who underwent to molecular diagnostics.
Methods: A study was conducted in hospitals in Baghdad, Iraq, on 66 infants during the follow-up period from March 2023 to March 2024. Patient data were extracted and analyzed using SPSS 22.0 on Iraqi newborn patients with sepsis. Our study recorded patient and clinical data, including demographics, maternal and neonatal characteristics, symptoms, and etiologies, which were analyzed for their impact on neonatal outcomes in the hospital.
Results: Based on our outcomes, all 66 patients' data were collected from hospitals. In terms of early-onset sepsis (EOS), we found fever got 88.89% and low birth weight (92.59%) were considered as the most common symptom and cause prevalence in patients, GBS (33.33%), E. COIL (25.93%), hospital stays (28.5 ± 3.4) days, mortality (22.22%), serious brain injury (22.22%), and retinopathy of prematurity ≥ 2 (33.33%). In terms of late-onset sepsis (LOS), it observed patients’ data following feeding intolerance got 75.0%, respiratory distress (35.0%), and coagulase-negative staphylococci (CoNS) (57.50%), staphylococcus aureus (67.50%) were considered as the most common symptom and cause prevalence in patients, CONS (55.0%), E. COIL (12.5%), hospital stays (11.6 ± 2.6) days, mortality (5.0%), serious brain injury (5.0%), and retinopathy of prematurity ≥ 2 (7.5%).
Conclusion: Sepsis continues to be associated with a higher risk of mortality and longer stays in hospitals, along with more chances of brain damage in survivors, although we have noted a decline in those patients with late-onset sepsis in juxtaposition to patients suffering from early-onset sepsis.
References
Pieren, D.K.J.; Boer, M.C.; de Wit, J. The adaptive immune system in early life: The shift makes it count. Front. Immunol. 2022, 13, 1031924.
Glaser, M.A.; Hughes, L.M.; Jnah, A.; Newberry, D. Neonatal Sepsis: A Review of Pathophysiology and Current Management Strategies. Adv. Neonatal Care 2021, 21, 49–60.
Shane, A.L.; Sánchez, P.J.; Stoll, B.J. Neonatal sepsis. Lancet 2017, 390, 1770–1780.
Cantey, J.B.; Lee, J.H. Biomarkers for the Diagnosis of Neonatal Sepsis. Clin. Perinatol. 2021, 48, 215–227.
van Veen, L.E.J.; van der Weijden, B.M.; Achten, N.B.; van der Lee, L.; Hol, J.; van Rossem, M.C.; Rijpert, M.; Oorthuys, A.O.J.; van Beek, R.H.T.; Dubbink-Verheij, G.H.; et al. Incidence of Antibiotic Exposure for Suspected and Proven Neonatal Early-Onset Sepsis between 2019 and 2021: A Retrospective, Multicentre Study. Antibiotics 2024, 13, 537.
Schulman, J.; Benitz, W.E.; Profit, J.; Lee, H.C.; Dueñas, G.; Bennett, M.V.; Jocson, M.A.L.; Schutzengel, R.; Gould, J.B. Newborn Antibiotic Exposures and Association With Proven Bloodstream Infection. Pediatrics 2019, 144, e20191105.
Kliegman, R.M.; Behrman, R.E.; Jenson, H.B.; Stanton, B.M. Nelson Textbook of Pediatrics E-Book; Elsevier Health Sciences: Amsterdam, The Netherlands, 2007.
Osrin, D.; Vergnano, S.; Costello, A. Serious bacterial infections in newborn infants in developing countries. Curr. Opin. Infect. Dis. 2004, 17, 217–224.
Oza, S.; Lawn, J.E.; Hogan, D.R.; Mathers, C.; Cousens, S.N. Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries: 2000–2013. Bull. World Health Organ. 2015, 93, 19–28.
Weston, E.J.; Pondo, T.; Lewis, M.M.; Martell-Cleary, P.; Morin, C.; Jewell, B.; Daily, P.; Apostol, M.; Petit, S.; Farley, M.; et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr. Infect. Dis. J. 2011, 30, 937–941.
Speier, R.L.; Cotten, C.M.; Benjamin, D.K., Jr.; Lewis, K.; Keeler, K.; Kidimbu, G.; Roberts, W.; Clark, R.H.; Zimmerman, K.O.; Stark, A.; et al. Late-Onset Sepsis Evaluation and Empiric Therapy in Extremely Low Gestational Age Newborns. J. Pediatr. Infect. Dis. Soc. 2023, 12, S37–S43.
Hayes, R.; Hartnett, J.; Semova, G.; Murray, C.; Murphy, K.; Carroll, L.; Plapp, H.; Hession, L.; O’Toole, J.; McCollum, D.; et al. Neonatal sepsis definitions from randomised clinical trials. Pediatr. Res. 2023, 93, 1141–1148.
Perlman, S.E.; Saiman, L.; Larson, E.L. Risk factors for late-onset healthcare-associated bloodstream infections in patients in neonatal intensive care units. Am. J. Infect. Control 2007, 35, 177–182.
Lemme-Dumit, J.M.; Song, Y.; Lwin, H.W.; Hernandez-Chavez, C.; Sundararajan, S.; Viscardi, R.M.; Ravel, J.; Pasetti, M.F.; Ma, B. Altered Gut Microbiome and Fecal Immune Phenotype in Early Preterm Infants With Leaky Gut. Front. Immunol. 2022, 13, 815046.
Simonsen, K.A.; Anderson-Berry, A.L.; Delair, S.F.; Davies, H.D. Early-Onset Neonatal Sepsis. Clin. Microbiol. Rev. 2014, 27, 21–47.
Berlak, N.; Shany, E.; Ben-Shimol, S.; Chertok, I.A.; Goldinger, G.; Greenberg, D.; Melamed, R. Late-onset sepsis: Comparison between coagulase-negative staphylococci and other bacteria in the neonatal intensive care unit. Infect. Dis. 2018, 50, 764–770.
Cai, S.; Thompson, D.K.; Anderson, P.J.; Yang, J.Y. Short- and Long-Term Neurodevelopmental Outcomes of Very Preterm Infants with Neonatal Sepsis: A Systematic Review and Meta-Analysis. Children 2019, 6, 131.
Sewell, E.; Roberts, J.; Mukhopadhyay, S. Association of Infection in Neonates and Long-Term Neurodevelopmental Outcome. Clin. Perinatol. 2021, 48, 251–261.
Kaya, G.; Usta, D.; Sag, E.; Aydin, Z.G.; Buruk, C.K.; Ozkaya, E.; Aydin, F.; Cakir, M. Incidence and Risk Factors for Antibiotic-associated Diarrhea Among Hospitalized Children. Pediatr. Infect. Dis. J. 2023, 42, 745–749.
Martinez, F.E.; Ferri, W.A.G.; Leone, C.R.; de Almeida, M.F.B.; Guinsburg, R.; Meneses, J.D.A.; Vale, M.S.D.; Marba, S.T.M.; de Carvalho, W.B.; de Souza Rugolo, L.M.S.; et al. Early Empiric Antibiotic Use Is Associated With Delayed Feeding Tolerance in Preterm Infants: A Retrospective Analysis. J. Pediatr. Gastroenterol. Nutr. 2017, 65, 107–110.
Abdel Ghany, E.A.; Ali, A.A. Empirical antibiotic treatment and the risk of necrotizing enterocolitis and death in very low birth weight neonates. Ann. Saudi Med. 2012, 32, 521–526.
Alexander, V.N.; Northrup, V.; Bizzarro, M.J. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J. Pediatr. 2011, 159, 392–397.
Cotten, C.M.; Taylor, S.; Stoll, B.; Goldberg, R.N.; Hansen, N.I.; Sánchez, P.J.; Ambalavanan, N.; Benjamin, D.K., Jr. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123, 58–66.
Kuppala, V.S.; Meinzen-Derr, J.; Morrow, A.L.; Schibler, K.R. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J. Pediatr. 2011, 159, 720–725.
Alonso-Ojembarrena, A.; Martínez-Díaz, J.V.; Lechuga-Sancho, A.M.; Galán-Sánchez, F.; Lubián-López, S.P. Broad spectrum antibiotics in newborns increase multi-drug resistant infections. J. Chemother. 2019, 31, 81–85.
Droste, J.H.; Wieringa, M.H.; Weyler, J.J.; Nelen, V.J.; Vermeire, P.A.; Van Bever, H.P. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin. Exp. Allergy 2000, 30, 1547–1553.
Duong, Q.A.; Pittet, L.F.; Curtis, N.; Zimmermann, P. Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis. J. Infect. 2022, 85, 213–300.
Hoskin-Parr, L.; Teyhan, A.; Blocker, A.; Henderson, A.J. Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: A dose-dependent relationship. Pediatr. Allergy Immunol. 2013, 24, 762–771.
Lin, Y.C.; Chen, Y.C.; Kuo, C.H.; Chang, Y.H.; Huang, H.Y.; Yeh, W.J.; Wu, T.Y.; Huang, M.Y.; Hung, C.H. Antibiotic exposure and asthma development in children with allergic rhinitis. J. Microbiol. Immunol. Infect. 2020, 53, 803–811.
Marra, F.; Marra, C.A.; Richardson, K.; Lynd, L.D.; Kozyrskyj, A.; Patrick, D.M.; Bowie, W.R.; FitzGerald, J.M. Antibiotic Use in Children Is Associated With Increased Risk of Asthma. Pediatrics 2009, 123, 1003–1010.